In Vitro Diagnostics (IVD) Market by Product Type (Reagents, Instruments, and Software & Services), Technique (Immunodiagnostics {Enzyme-Linked Immunosorbent Assay [Chemiluminescence Immunoassay (CLIA), Fluorescence Immunoassay (FIA), and Colorimetric Immunoassay (CI)], Rapid Tests, Enzyme-Linked ImmunoSpot (ELISPOT), Radioimmunoassay (RIA), and Western Blot}, Hematology, Molecular Diagnostics {Polymerize Chain Reaction (PCR), Isothermal Nucleic Acid Technology (INAAT), Hybridization, DNA Diagnostics, Microarray, and Others}, Tissue Diagnostics, Clinical Chemistry {Basic Metabolic Panel, Liver Panel, Lipid Profile, Thyroid Function Panel, Electrolyte Panel, and Specialty Chemicals}, and Other IVD Techniques), Application (Infectious Diseases, Cancer, Cardiac Diseases, Immune System Disorders, Nephrological Diseases, Gastrointestinal Diseases, and Other Indications), and End User (Standalone Laboratory, Hospitals, Academic & Medical Schools, Point of Care Testing, and Others): Global Opportunity Analysis and Industry Forecast, 2018 - 2025
- Published Date: 2020-10-18
- Report ID: 3316
- Pages: 377
-
Format:
IVD Market Overview:
The global in vitro diagnostics (IVD) market was valued at $64,479 million in 2017, and is estimated to reach at $93,614 million by 2025, registering a CAGR of 4.8% from 2018 to 2025.
In vitro diagnostic (IVD) is a technique in which medical devices and reagents are used to examine specimens such as blood, urine, stool, tissues, and other body fluids, which are derived from the human body to detect diseases, conditions, and infections. The tests can be performed in stand-alone laboratory, hospital-based laboratory, and point of care. Some of the significant technologies incorporated in IVD include polymerase chain reaction (PCR), microarray techniques, sequencing technology, and mass spectrometry, which are used for test sample preparation. Incessant innovations in IVD product type design and technology have encouraged doctors and researchers to shift their focus from traditional diagnostic methods to personalized medicines.
Rise in need for IVD testing arises due to increase in incidences of chronic and infectious diseases and growth in geriatric population prone to immunological disorders. Moreover, advancements in personalized medicines and widespread knowledge of rare diseases are expected to boost the growth of the global IVD market. In addition, increase in incidences of colorectal cancer, neurological disorders, and gynecological diseases are anticipated to boost the adoption of IVD devices and reagents. On the contrary, stringent government regulations and unfavorable reimbursement policies are expected to restrain the growth of the global market.
The report segments the market across different categories such as product type, technique, application, end users, and region. Based on product type, the market is segmented into reagents, instruments, and services & software.
Based on techniques, the market is segmented into immunodiagnostics, hematology, molecular diagnostics, tissue diagnostics, clinical chemistry, and other IVD techniques. The immunodiagnostics is further segmented into enzyme-linked immunosorbent assay (ELISA), rapid tests, enzyme-linked immunospot (ELISPOT), radioimmunoassay (RIA), and western blot. The ELISA segment is further classified into chemiluminescence immunoassay (CLIA), fluorescence immunoassay (FIA), and colorimetric immunoassay (CI). Molecular diagnostics segment is further divided into polymerase chain reaction (PCR), isothermal nucleic acid amplification technology (INAAT), hybridization, DNA diagnostics, microarrays, and others. Similarly, clinical chemistry segment is categorized into basic metabolic panel, liver panel, lipid profile, thyroid function panel, renal profile, electrolyte panel, and specialty chemicals.
By application, the market is classified into infectious diseases, cancer, cardiac diseases, immune system disorders, nephrological diseases, gastrointestinal diseases, and other indications. Based on end user, it is divided into hospitals, academic & medical schools, point of care testing, and others. Based on region, the market is studied across North America (U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
Key players profiled in the report include Abbott Laboratories; Becton, Dickinson and Company; bioMrieux SA, Bio-Rad Laboratories, Inc.; Danaher Corporation (Beckman Coulter, Inc.); F. Hoffmann-La Roche Ltd.; Johnson & Johnson; QIAGEN N.V.; Sysmex Corporation; and Thermo Fisher Scientific, Inc.
Key Benefits for IVD Market:
The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
It offers a quantitative analysis from 2017 to 2025, which is expected to enable the stakeholders to capitalize on the prevailing market opportunities.
A comprehensive analysis of all the geographical regions is provided to determine the existing opportunities.
The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global market.
IVD Key Market Segments:
By Product Type
Reagents
Instruments
Software & Services
By Techniques
Immunodiagnostics
Enzyme-Linked Immunosorbent Assay (ELISA)
Chemiluminescence Immunoassays (CLIAS)
Fluorescence Immunoassays (FIAS)
Colorimetric Immunoassays (CIS)
Rapid Tests
Enzyme-Linked ImmunoSpot Assays (ELISPOT)
Radioimmunoassay
Western Blot
Hematology
Molecular Diagnostics
Polymerase Chain Reaction (PCR)
Isothermal Nucleic Acid Amplification Technology (INAAT)
Hybridization
DNA Diagnostics
Microarrays
Others
Tissue Diagnostics
Clinical Chemistry
Basic Metabolic Panel
Liver Panel
Lipid Profile
Thyroid Function Panel
Renal Profile
Electrolyte Panel
Specialty Chemicals
Other IVD Techniques
By End User
Standalone Laboratory
Hospitals
Academic & Medical Schools
Point of Care Testing
Others
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
Australia
India
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
List Of Key Players Profiled in the Report
Abbott Laboratories
Becton, Dickinson and Company
bioMrieux SA
Bio-Rad Laboratories, Inc.
Danaher Corporation (Beckman Coulter, Inc.)
F. Hoffmann-La Roche Ltd.
Johnson & Johnson
QIAGEN N.V.
Sysmex Corporation
Thermo Fisher Scientific, Inc.
List Of Other Players in the Value Chain (These players are not profiled in the report. The same will be included on request)
Illumina, Inc.
Luminex Corporation.
Siemens Healthcare GmbH.
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.3.1. List of key players profiled in the report
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.3. Top winning strategies, 2017
3.4. Top player positioning, 2017
3.5. Porters five forces analysis
3.6. Market dynamics
3.6.1. Drivers
3.6.1.1. Increase in incidence of chronic and infectious diseases
3.6.1.2. Technological advancements in IVD
3.6.1.3. Emergence of minimal invasive technologies
3.6.1.4. Increasing government expenditures on healthcare
3.6.1.5. Increase in popularity of personalized medicine approach
3.6.2. Restraint
3.6.2.1. Unclear reimbursement policies
3.6.2.2. Stringent regulatory policies
3.6.3. Opportunities
3.6.3.1. Potential opportunities for outsourcing
3.6.3.2. Convergence of new technologies
3.6.4. Impact Analyses
CHAPTER 4: IN-VITRO DIAGNOSTICS MARKET, BY PRODUCT TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Reagents
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country
4.3. Instruments
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country
4.4. Software & Services
4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market analysis, by country
CHAPTER 5: IN-VITRO DIAGNOSTICS MARKET, BY TECHNIQUE
5.1. Overview
5.1.1. Market size and forecast
5.2. Immunodiagnostics
5.2.1. Market size and forecast, by type
5.2.1.1. Enzyme-Linked Immunosorbent Assay (ELISA)
5.2.1.1.1. Market size and forecast
5.2.1.1.2. Chemiluminescence Immunoassay (CLIA)
5.2.1.1.2.1. Market size and forecast
5.2.1.1.3. Fluorescence Immunoassay (FIA)
5.2.1.1.3.1. Market size and forecast
5.2.1.1.4. Colorimetric Immunoassay (CI)
5.2.1.1.4.1. Market size and forecast
5.2.1.2. Rapid Tests
5.2.1.2.1. Market size and forecast
5.2.1.3. Enzyme-Linked ImmunoSpot (ELISPOT)
5.2.1.3.1. Market size and forecast
5.2.1.4. Radioimmunoassay (RIA)
5.2.1.4.1. Market size and forecast
5.2.1.5. Western Blot
5.2.1.5.1. Market size and forecast
5.2.2. Market size and forecast, by region
5.2.3. Market analysis, by country
5.3. Hematology
5.3.1. Market size and forecast, by region
5.3.2. Market share analysis, by country
5.4. Molecular Diagnostics
5.4.1. Market size and forecast, by type
5.4.1.1. Polymerize Chain Reaction (PCR)
5.4.1.1.1. Market size and forecast
5.4.1.2. Isothermal Nucleic Acid Technology (INAAT)
5.4.1.2.1. Market size and forecast
5.4.1.3. Hybridization
5.4.1.3.1. Market size and forecast
5.4.1.4. DNA Diagnostics
5.4.1.4.1. Market size and forecast
5.4.1.5. Microarray
5.4.1.5.1. Market size and forecast
5.4.1.6. Others
5.4.1.6.1. Market size and forecast
5.4.2. Market size and forecast, by region
5.4.3. Market share analysis, by country
5.5. Tissue Diagnostics
5.5.1. Market size and forecast, by region
5.5.2. Market share analysis, by country
5.6. Clinical Chemistry
5.6.1. Market size and forecast, by type
5.6.1.1. Basic Metabolic Panel
5.6.1.1.1. Market size and forecast
5.6.1.2. Liver Panel
5.6.1.2.1. Market size and forecast
5.6.1.3. Renal Profile
5.6.1.3.1. Market size and forecast
5.6.1.4. Lipid Profile
5.6.1.4.1. Market size and forecast
5.6.1.5. Thyroid Function Panel
5.6.1.5.1. Market size and forecast
5.6.1.6. Electrolyte Panel
5.6.1.6.1. Market size and forecast
5.6.1.7. Specialty Chemicals
5.6.1.7.1. Market size and forecast
5.6.2. Market size and forecast, by region
5.6.3. Market share analysis, by country
5.7. Others
5.7.1. Market size and forecast, by region
5.7.2. Market share analysis, by country
CHAPTER 6: IN-VITRO DIAGNOSTICS MARKET, BY APPLICATION
6.1. Overview
6.1.1. Market size and forecast
6.2. Infectious Diseases
6.2.1. Market size and forecast, by region
6.2.2. Market share analysis
6.3. Cancer
6.3.1. Market size and forecast, by region
6.3.2. Market share analysis, by country
6.4. Cardiac Diseases
6.4.1. Market size and forecast, by region
6.4.2. Market share analysis, by country
6.5. Immune System Disorders
6.5.1. Market size and forecast, by region
6.5.2. Market share analysis, by country
6.6. Nephrological Diseases
6.6.1. Market size and forecast, by region
6.6.2. Market share analysis
6.7. Gastrointestinal Diseases
6.7.1. Market size and forecast, by region
6.7.2. Market share analysis
6.8. Others
6.8.1. Market size and forecast, by region
6.8.2. Market share analysis
CHAPTER 7: IN-VITRO DIAGNOSTICS MARKET, BY END USER
7.1. Overview
7.1.1. Market size and forecast
7.2. Stand-Alone Laboratory
7.2.1. Market size and forecast, by region
7.2.2. Market share analysis, by country
7.3. Hospitals
7.3.1. Market size and forecast, by region
7.3.2. Market share analysis, by country
7.4. Academic & Medical Schools
7.4.1. Market size and forecast, by region
7.4.2. Market share analysis
7.5. Point of Care Testing
7.5.1. Market size and forecast, by region
7.5.2. Market share analysis
7.6. Others
7.6.1. Market size and forecast, by region
7.6.2. Market share analysis, by country
CHAPTER 8: IN-VITRO DIAGNOSTICS MARKET, BY REGION
8.1. Overview
8.1.1. Market size and forecast
8.2. North America
8.2.1. Key market trends, growth factors, and opportunities
8.2.2. Market size and forecast, by country
8.2.2.1. U.S.
8.2.2.1.1. U.S. In-vitro diagnostics market, by product type
8.2.2.1.2. U.S. In-vitro diagnostics market, by technique
8.2.2.1.3. U.S. In-vitro diagnostics market, by application
8.2.2.1.4. U.S. In-vitro diagnostics market, by end user
8.2.2.2. Canada
8.2.2.2.1. Canada In-vitro diagnostics market, by product type
8.2.2.2.2. Canada In-vitro diagnostics market, by technique
8.2.2.2.3. Canada In-vitro diagnostics market, by application
8.2.2.2.4. Canada In-vitro diagnostics market, by end user
8.2.2.3. Mexico
8.2.2.3.1. Mexico In-vitro diagnostics market, by product type
8.2.2.3.2. Mexico In-vitro diagnostics market, by technique
8.2.2.3.3. Mexico In-vitro diagnostics market, by application
8.2.2.3.4. Mexico In-vitro diagnostics market, by end user
8.2.3. Market size and forecast, by product type
8.2.4. Market size and forecast, by technique
8.2.5. Market size and forecast, by application
8.2.6. Market size and forecast, by end user
8.3. Europe
8.3.1. Key market trends, growth factors, and opportunities
8.3.2. Market size and forecast, by country
8.3.2.1. Germany
8.3.2.1.1. Germany In-vitro diagnostics market, by product type
8.3.2.1.2. Germany In-vitro diagnostics market, by technique
8.3.2.1.3. Germany In-vitro diagnostics market, by application
8.3.2.1.4. Germany In-vitro diagnostics market, by end user
8.3.2.2. France
8.3.2.2.1. France In-vitro diagnostics market, by product type
8.3.2.2.2. France In-vitro diagnostics market, by technique
8.3.2.2.3. France In-vitro diagnostics market, by application
8.3.2.2.4. France In-vitro diagnostics market, by end user
8.3.2.3. UK
8.3.2.3.1. UK In-vitro diagnostics market, by product type
8.3.2.3.2. UK In-vitro diagnostics market, by technique
8.3.2.3.3. UK In-vitro diagnostics market, by application
8.3.2.3.4. UK In-vitro diagnostics market, by end user
8.3.2.4. Italy
8.3.2.4.1. Italy In-vitro diagnostics market, by product type
8.3.2.4.2. Italy In-vitro diagnostics market, by technique
8.3.2.4.3. Italy In-vitro diagnostics market, by application
8.3.2.4.4. Italy In-vitro diagnostics market, by end user
8.3.2.5. Spain
8.3.2.5.1. Spain In-vitro diagnostics market, by product type
8.3.2.5.2. Spain In-vitro diagnostics market, by technique
8.3.2.5.3. Spain In-vitro diagnostics market, by application
8.3.2.5.4. Spain In-vitro diagnostics market, by end user
8.3.2.6. Rest of Europe
8.3.2.6.1. Rest of Europe In-vitro diagnostics market, by product t type
8.3.2.6.2. Rest of Europe In-vitro diagnostics market, by technique
8.3.2.6.3. Rest of Europe In-vitro diagnostics market, by application
8.3.2.6.4. Rest of Europe In-vitro diagnostics market, by end user
8.3.3. Market size and forecast, by product type
8.3.4. Market size and forecast, by technique
8.3.5. Market size and forecast, by application
8.3.6. Market size and forecast, by end user
8.4. Asia-Pacific
8.4.1. Key market trends, growth factors, and opportunities
8.4.2. Market size and forecast, by country
8.4.2.1. Japan
8.4.2.1.1. Japan In-vitro diagnostics market, by product type
8.4.2.1.2. Japan In-vitro diagnostics market, by technique
8.4.2.1.3. Japan In-vitro diagnostics market, by application
8.4.2.1.4. Japan In-vitro diagnostics market, by end user
8.4.2.2. China
8.4.2.2.1. China In-vitro diagnostics market, by product type
8.4.2.2.2. China In-vitro diagnostics market, by technique
8.4.2.2.3. China In-vitro diagnostics market, by application
8.4.2.2.4. China In-vitro diagnostics market, by end user
8.4.2.3. Australia
8.4.2.3.1. Australia In-vitro diagnostics market, by product type
8.4.2.3.2. Australia In-vitro diagnostics market, by technique
8.4.2.3.3. Australia In-vitro diagnostics market, by application
8.4.2.3.4. Australia In-vitro diagnostics market, by end user
8.4.2.4. India
8.4.2.4.1. India In-vitro diagnostics market, by product type
8.4.2.4.2. India In-vitro diagnostics market, by technique
8.4.2.4.3. India In-vitro diagnostics market, by application
8.4.2.4.4. India In-vitro diagnostics market, by end user
8.4.2.5. South Korea
8.4.2.5.1. South Korea In-vitro diagnostics market, by product type
8.4.2.5.2. South Korea In-vitro diagnostics market, by technique
8.4.2.5.3. South Korea In-vitro diagnostics market, by application
8.4.2.5.4. South Korea In-vitro diagnostics market, by end user
8.4.2.6. Rest of Asia-Pacific
8.4.2.6.1. Rest of Asia-Pacific In-vitro diagnostics market, by product type
8.4.2.6.2. Rest of Asia-Pacific In-vitro diagnostics market, by technique
8.4.2.6.3. Rest of Asia-Pacific In-vitro diagnostics market, by application
8.4.2.6.4. Rest of Asia-Pacific In-vitro diagnostics market, by end user
8.4.3. Market size and forecast, by product type
8.4.4. Market size and forecast, by technique
8.4.5. Market size and forecast, by indication
8.4.6. Market size and forecast, by end user
8.5. LAMEA
8.5.1. Key market trends, growth factors, and opportunities
8.5.2. Market size and forecast, by country
8.5.2.1. Brazil
8.5.2.1.1. Brazil In-vitro diagnostics market, by product type
8.5.2.1.2. Brazil In-vitro diagnostics market, by technique
8.5.2.1.3. Brazil In-vitro diagnostics market, by application
8.5.2.1.4. Brazil In-vitro diagnostics market, by end user
8.5.2.2. Saudi Arabia
8.5.2.2.1. Saudi Arabia In-vitro diagnostics market, by product type
8.5.2.2.3. Saudi Arabia In-vitro diagnostics market, by technique
8.5.2.2.4. Saudi Arabia In-vitro diagnostics market, by application
8.5.2.2.5. Saudi Arabia In-vitro diagnostics market, by end user
8.5.2.3. South Africa
8.5.2.3.1. South Africa In-vitro diagnostics market, by product type
8.5.2.3.2. South Africa In-vitro diagnostics market, by technique
8.5.2.3.3. South Africa In-vitro diagnostics market, by application
8.5.2.3.4. South Africa In-vitro diagnostics market, by end user
8.5.2.4. Rest of LAMEA
8.5.2.4.1. Rest of LAMEA In-vitro diagnostics market, by product type
8.5.2.4.2. Rest of LAMEA In-vitro diagnostics market, by technique
8.5.2.4.3. Rest of LAMEA In-vitro diagnostics market, by application
8.5.2.4.4. Rest of LAMEA In-vitro diagnostics market, by end user
8.5.3. Market size and forecast, by product type
8.5.4. Market size and forecast, by technique
8.5.5. Market size and forecast, by application
8.5.6. Market size and forecast, by end user
CHAPTER 9: COMPANY PROFILES
9.1. Abbott Laboratories
9.1.1. Company overview
9.1.2. Company snapshot
9.1.3. Operating business segments
9.1.4. Product type Portfolio
9.1.5. Business performance
9.1.6. Key strategic moves and developments
9.2. Becton, Dickinson and Company
9.2.1. Company overview
9.2.2. Company snapshot
9.2.3. Operating business segments
9.2.4. Product type Portfolio
9.2.5. Business performance
9.2.6. Key strategic moves and developments
9.3. bioMrieux SA
9.3.1. Company overview
9.3.2. Company snapshot
9.3.3. Product type portfolio
9.3.4. Business performance
9.3.5. Key strategic moves and developments
9.4. Bio-Rad Laboratories, Inc.
9.4.1. Company overview
9.4.2. Company snapshot
9.4.3. Operating business segments
9.4.4. Product type Portfolio
9.4.5. Business performance
9.4.6. Key strategic moves and developments
9.5. Danaher Corporation (Beckman Coulter, Inc.)
9.5.1. Company overview
9.5.2. Company snapshot
9.5.3. Operating business segments
9.5.4. Product type portfolio
9.5.5. Business performance
9.5.6. Key strategic moves and developments
9.6. F. Hoffmann-La Roche Ltd.
9.6.1. Company overview
9.6.2. Company snapshot
9.6.3. Operating business segments
9.6.4. Product type portfolio
9.6.5. Business performance
9.6.6. Key strategic moves and developments
9.7. Johnson & Johnson
9.7.1. Company overview
9.7.2. Company snapshot
9.7.3. Operating business segments
9.7.4. Product type Portfolio
9.7.5. Business performance
9.7.6. Key strategic moves and developments
9.8. QIAGEN N.V.
9.8.1. Company overview
9.8.2. Company snapshot
9.8.3. Product type portfolio
9.8.4. Business performance
9.9. Sysmex Corporation
9.9.1. Company overview
9.9.2. Company snapshot
9.9.3. Operating business segments
9.9.4. Product type Portfolio
9.9.5. Business performance
9.10. Thermo Fisher Scientific, Inc.
9.10.1. Company overview
9.10.2. Company snapshot
9.10.3. Operating business segments
9.10.4. Product type Portfolio
9.10.5. Business performance
9.10.6. Key strategic moves and developments
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
